This prospective, longitudinal study assessed the association between cardiovascular disease and glaucoma.

In this interview from AGS 2021, Dr. Davinder Grover shares an ab interno approach to managing tube-related hypotony.

This week, Glaukos reports positive results from 2 glaucoma trials, CorNeat Vision’s artificial cornea is implanted into its first trial participant and Notal Vision tests out their at-home OCT platform for monitoring AMD.

Weekly case challenge

This large retrospective study evaluated the outcomes of selective laser trabeculoplasty.

Allergan’s bimatoprost implant (Durysta) is now the first approved intracameral, sustained-release therapy for lowering IOP in patients with open-angle glaucoma or ocular hypertension.

Weekly case challenge

This study compared the efficacy of a fixed-dose netarsudil/latanoprost combination therapy versus individual monotherapies for open-angle glaucoma and ocular hypertension.

Normal-tension glaucoma (NTG) is an optic neuropathy of unknown etiology characterized by optic disc excavation, retinal nerve fiber layer loss, and visual field defects similar to those seen in other forms of glaucomatous optic neuropathy. Patients with glaucomalike optic nerve and visual field changes yet normal intraocular pressure are numerous and require treatment to preserve vision.